Different immunohistochemical patterns of Fhit protein expression in renal neoplasms

Eduardo Eyzaguirre, Markku Miettinen, Brent A. Norris, Zoran Gatalica

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: The FHIT gene on human chromosome 3p14.2 is deleted in a variety of malignant tumors, including clear cell renal carcinomas (RCCs) resulting in a loss of expression of Fhit protein. The Fhit expression in specific subtypes of renal carcinomas has not been characterized. We have investigated the association of Fhit expression with particular subtypes of renal tumors to determine the role and specificity of this putative tumor suppressor gene in renal neoplasia. Material and Methods: The immunohistochemical expression of Fhit was tested in normal kidneys and in 109 renal neoplasms consisting of 51 clear cell RCCs, 26 papillary RCCs, two chromophobe carcinomas, six oncocytomas, four pelvic transitional cell carcinomas and 20 Wilms' tumors from formalin fixed and routinely processed tissue. Results: Normal renal tubules expressed Fhit strongly and consistently. The majority (78%) of clear cell RCCs showed reduced or absent expression of Fhit, whereas the majority (74%) of papillary carcinomas, all chromophobe renal cell carcinomas, and oncocytomas were strongly positive. Sixty-eight percent of low-grade (G1 plus G2) but only 9% of high-grade (G3 plus G4) clear cell carcinomas were Fhit negative. Wilms' tumors demonstrated focal staining in the epithelial component in 8 of 20 cases (40%). Conclusions: The loss of Fhit expression in a high percentage of clear cell RCCs with conservation of Fhit in other types of tumors supports the proposed role of FHIT alterations in the genesis of clear cell carcinomas in contrast to other types of renal epithelial tumors. FHIT expression may play a role in epithelial differentiation of nephroblastomas (Wilms' tumors).

Original languageEnglish (US)
Pages (from-to)979-983
Number of pages5
JournalModern Pathology
Volume12
Issue number10
StatePublished - Oct 1999

Fingerprint

Kidney Neoplasms
Renal Cell Carcinoma
Wilms Tumor
Kidney
Proteins
Carcinoma
Papillary Carcinoma
Neoplasms
Oxyphilic Adenoma
Transitional Cell Carcinoma
Human Chromosomes
Tumor Suppressor Genes
Formaldehyde
Staining and Labeling
Genes

Keywords

  • Chromosome 3p
  • FHIT
  • FRA3B fragile site
  • Immunohistochemistry
  • Renal cell carcinoma
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Eyzaguirre, E., Miettinen, M., Norris, B. A., & Gatalica, Z. (1999). Different immunohistochemical patterns of Fhit protein expression in renal neoplasms. Modern Pathology, 12(10), 979-983.

Different immunohistochemical patterns of Fhit protein expression in renal neoplasms. / Eyzaguirre, Eduardo; Miettinen, Markku; Norris, Brent A.; Gatalica, Zoran.

In: Modern Pathology, Vol. 12, No. 10, 10.1999, p. 979-983.

Research output: Contribution to journalArticle

Eyzaguirre, E, Miettinen, M, Norris, BA & Gatalica, Z 1999, 'Different immunohistochemical patterns of Fhit protein expression in renal neoplasms', Modern Pathology, vol. 12, no. 10, pp. 979-983.
Eyzaguirre, Eduardo ; Miettinen, Markku ; Norris, Brent A. ; Gatalica, Zoran. / Different immunohistochemical patterns of Fhit protein expression in renal neoplasms. In: Modern Pathology. 1999 ; Vol. 12, No. 10. pp. 979-983.
@article{39c3ed8f9c224a53b44426c602c08c82,
title = "Different immunohistochemical patterns of Fhit protein expression in renal neoplasms",
abstract = "Background: The FHIT gene on human chromosome 3p14.2 is deleted in a variety of malignant tumors, including clear cell renal carcinomas (RCCs) resulting in a loss of expression of Fhit protein. The Fhit expression in specific subtypes of renal carcinomas has not been characterized. We have investigated the association of Fhit expression with particular subtypes of renal tumors to determine the role and specificity of this putative tumor suppressor gene in renal neoplasia. Material and Methods: The immunohistochemical expression of Fhit was tested in normal kidneys and in 109 renal neoplasms consisting of 51 clear cell RCCs, 26 papillary RCCs, two chromophobe carcinomas, six oncocytomas, four pelvic transitional cell carcinomas and 20 Wilms' tumors from formalin fixed and routinely processed tissue. Results: Normal renal tubules expressed Fhit strongly and consistently. The majority (78{\%}) of clear cell RCCs showed reduced or absent expression of Fhit, whereas the majority (74{\%}) of papillary carcinomas, all chromophobe renal cell carcinomas, and oncocytomas were strongly positive. Sixty-eight percent of low-grade (G1 plus G2) but only 9{\%} of high-grade (G3 plus G4) clear cell carcinomas were Fhit negative. Wilms' tumors demonstrated focal staining in the epithelial component in 8 of 20 cases (40{\%}). Conclusions: The loss of Fhit expression in a high percentage of clear cell RCCs with conservation of Fhit in other types of tumors supports the proposed role of FHIT alterations in the genesis of clear cell carcinomas in contrast to other types of renal epithelial tumors. FHIT expression may play a role in epithelial differentiation of nephroblastomas (Wilms' tumors).",
keywords = "Chromosome 3p, FHIT, FRA3B fragile site, Immunohistochemistry, Renal cell carcinoma, Tumor suppressor gene",
author = "Eduardo Eyzaguirre and Markku Miettinen and Norris, {Brent A.} and Zoran Gatalica",
year = "1999",
month = "10",
language = "English (US)",
volume = "12",
pages = "979--983",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Different immunohistochemical patterns of Fhit protein expression in renal neoplasms

AU - Eyzaguirre, Eduardo

AU - Miettinen, Markku

AU - Norris, Brent A.

AU - Gatalica, Zoran

PY - 1999/10

Y1 - 1999/10

N2 - Background: The FHIT gene on human chromosome 3p14.2 is deleted in a variety of malignant tumors, including clear cell renal carcinomas (RCCs) resulting in a loss of expression of Fhit protein. The Fhit expression in specific subtypes of renal carcinomas has not been characterized. We have investigated the association of Fhit expression with particular subtypes of renal tumors to determine the role and specificity of this putative tumor suppressor gene in renal neoplasia. Material and Methods: The immunohistochemical expression of Fhit was tested in normal kidneys and in 109 renal neoplasms consisting of 51 clear cell RCCs, 26 papillary RCCs, two chromophobe carcinomas, six oncocytomas, four pelvic transitional cell carcinomas and 20 Wilms' tumors from formalin fixed and routinely processed tissue. Results: Normal renal tubules expressed Fhit strongly and consistently. The majority (78%) of clear cell RCCs showed reduced or absent expression of Fhit, whereas the majority (74%) of papillary carcinomas, all chromophobe renal cell carcinomas, and oncocytomas were strongly positive. Sixty-eight percent of low-grade (G1 plus G2) but only 9% of high-grade (G3 plus G4) clear cell carcinomas were Fhit negative. Wilms' tumors demonstrated focal staining in the epithelial component in 8 of 20 cases (40%). Conclusions: The loss of Fhit expression in a high percentage of clear cell RCCs with conservation of Fhit in other types of tumors supports the proposed role of FHIT alterations in the genesis of clear cell carcinomas in contrast to other types of renal epithelial tumors. FHIT expression may play a role in epithelial differentiation of nephroblastomas (Wilms' tumors).

AB - Background: The FHIT gene on human chromosome 3p14.2 is deleted in a variety of malignant tumors, including clear cell renal carcinomas (RCCs) resulting in a loss of expression of Fhit protein. The Fhit expression in specific subtypes of renal carcinomas has not been characterized. We have investigated the association of Fhit expression with particular subtypes of renal tumors to determine the role and specificity of this putative tumor suppressor gene in renal neoplasia. Material and Methods: The immunohistochemical expression of Fhit was tested in normal kidneys and in 109 renal neoplasms consisting of 51 clear cell RCCs, 26 papillary RCCs, two chromophobe carcinomas, six oncocytomas, four pelvic transitional cell carcinomas and 20 Wilms' tumors from formalin fixed and routinely processed tissue. Results: Normal renal tubules expressed Fhit strongly and consistently. The majority (78%) of clear cell RCCs showed reduced or absent expression of Fhit, whereas the majority (74%) of papillary carcinomas, all chromophobe renal cell carcinomas, and oncocytomas were strongly positive. Sixty-eight percent of low-grade (G1 plus G2) but only 9% of high-grade (G3 plus G4) clear cell carcinomas were Fhit negative. Wilms' tumors demonstrated focal staining in the epithelial component in 8 of 20 cases (40%). Conclusions: The loss of Fhit expression in a high percentage of clear cell RCCs with conservation of Fhit in other types of tumors supports the proposed role of FHIT alterations in the genesis of clear cell carcinomas in contrast to other types of renal epithelial tumors. FHIT expression may play a role in epithelial differentiation of nephroblastomas (Wilms' tumors).

KW - Chromosome 3p

KW - FHIT

KW - FRA3B fragile site

KW - Immunohistochemistry

KW - Renal cell carcinoma

KW - Tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=0032850341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032850341&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 979

EP - 983

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 10

ER -